Cardiology Today Current Issue
The following articles appeared in the print edition of Cardiology Today.
Table of Contents
- Awareness of women’s heart health has increased, but more research, outreach required
-
- FDA approves expanded indication for empagliflozin to reduce CV death in type 2 diabetes
- FDA: Health benefits of St. Jude Medical implantable devices outweigh cybersecurity risks
- 2 decades of hypertension George L. Bakris, MD
- Report: Workplace improvements needed for childbearing cardiologists
- Model helps predict which patients with HF may benefit from ICD
- ACE inhibitors slow progression of myocardial fibrosis in patients with muscular dystrophy
- ACP, AAFP recommend ‘less aggressive’ systolic BP target for older patients with hypertension
- Activity in amygdala predicts CV events
-
- AHA: With proper management, successful pregnancy feasible for women with complex congenital heart disease
- Alcohol abuse increases CVD risk
- CVD incidence in veterans reduced by lifestyle change program
- Elevated systolic BP, related deaths rose worldwide over 25 years; burden in US high
- HIV status significantly influences HF outcomes in women
- Increased conflict of interest policies needed for guideline committees, advocacy organizations
- Most patients fail to receive high-potency statins after ACS
- New review on dietary sugar guidelines spark debate
-
- Omega-3 fatty acids, dark fish not associated with elevated CVD risk in women
- One-year TAVR outcomes superior in women vs. men
- Personal, professional lives of cardiologists vary between sexes
- Predictors for discontinuation of warfarin therapy identified
- Thrombolysis treatment within 1 hour linked to best outcomes for acute ischemic stroke
- Type 2 MI in patients with HIV often caused by unconventional factors
- Court grants injunction to prevent US sales of alirocumab due to patent infringement
- Outcomes after stroke not influenced by sex after adjustment for confounders
-
- Drug therapy for managing primary orthostatic hypotension Genevieve Hale, PharmD, BCPS; Sarah A. Spinler, PharmD, FCCP, FAHA, FASHP, AACC, BCPS (AQ Cardiology)
- Trial Scorecard: AF-CHF
- Trial Scorecard: BVS-EXPAND
- Trial Scorecard: COSM
- Trial Scorecard: FREEDOM
- Trial Scorecard: PSY-HEART
- Trial Scorecard: SHIELD-2
- Trial Scorecard: TORO
-
- Trial Scorecard: YELLOW II
- Matters of the heart and mind Ki Park, MD, MS, FSCAI